HRMY logo

HRMY Stock Overview

Profile

Full Name:

Harmony Biosciences Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

August 19, 2020

Indexes:

Not included

Website:

http://www.harmonybiosciences.com

Description:

Harmony Biosciences Holdings (HRMY) focuses on developing and commercializing innovative treatments for rare neurological disorders. The company aims to improve the lives of patients with conditions like narcolepsy by providing effective therapies that address unmet medical needs in the healthcare market.

Key Details

Price

$33.30

Market Cap

$1.91 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$714.73 M(+22.80% YoY)

Annual EPS

$2.51(+17.84% YoY)

PE Ratio

13.27

Annual ROE

25.84%

Annual Debt To Equity

0.27

Beta

1.00

Events Calendar

Earnings

Next earnings date:

Apr 30, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 HC Wainwright & Co.
Buy
Feb 26, 25 Needham
Buy
Feb 25, 25 Needham
Buy
Feb 20, 25 Mizuho
Outperform
Feb 19, 25 Needham
Buy
Feb 19, 25 HC Wainwright & Co.
Buy
Feb 11, 25 Deutsche Bank
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Jan 16, 25 HC Wainwright & Co.
Buy
Jan 13, 25 Needham
Buy

Screeners with HRMY included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$33.30
HRMY price is $33.30

Price All-time High

$61.00
HRMY price is currently -45.41% below its historical high of $61.00

Price Analysts Target

$52.00
HRMY price is currently -35.96% lower than the consensus analysts' forecast

Price Most Recent Change

-1.62%
HRMY price was down -1.62% on Mar 3, 2025

Price YTD Change

-3.23%
HRMY price is down -3.23% since January 1st

Price 3-Year Change

-20.03%
HRMY price is down -20.03% over the past 3 years

Market cap

Market Cap

$1.91 B
HRMY market capitalization is $1.91 billion

Market Cap 3-Year Change

-22.1%
HRMY market capitalization is down -22.1% over the past 3 years

Market Cap All-time High

$3.62 B
HRMY market capitalization is currently -47.22% below its historical high of $3.62 billion

Market Cap Sector Rank

81.99%
HRMY market capitalization is higher than 81.99% of companies in Healthcare sector

Technical

Beta

1.00
HRMY beta is 1.00

200-day SMA

$34.38
HRMY price is currently -3.14% below its 200-day simple moving average

14-day RSI

36.16
HRMY 14-day relative strength index is 36.16

30-day Relative Volume

1.00
HRMY 30-day relative volume is 1.00

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$714.73 M
HRMY annual revenue is $714.73 million

Annual Revenue Analysts Estimate

$842.40 M
HRMY annual revenue is currently -15.16% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+22.8%
HRMY annual revenue is up +22.8% year-on-year

Annual Revenue Sector Rank

77.58%
HRMY annual revenue is higher than 77.58% of companies in Healthcare sector

Profit

Annual Gross Profit

$557.92 M
HRMY annual gross profit is $557.92 million

Annual Gross Margin

78.06%
HRMY annual gross profit margin is 78.06%

Annual Operating Profit

$190.83 M
HRMY annual operating income is $190.83 million

Annual Operating Margin

26.70%
HRMY annual operating profit margin is 26.70%

Annual Net Income

$145.49 M
HRMY annual net profit is $145.49 million

Annual Net Margin

20.36%
HRMY annual net profit margin is 20.36%

EPS

Annual EPS

$2.51
HRMY annual earnings per share is $2.51

Annual EPS Analysts Estimate

$3.82
HRMY annual earnings per share is currently -34.29% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+17.84%
HRMY annual earnings per share is up +17.84% year-on-year

Annual EPS Sector Rank

93.04%
HRMY annual earnings per share is higher than 93.04% of companies in Healthcare sector

ROA & ROE

Annual ROA

16.07%
HRMY annual return on assets is 16.07%

Annual ROE

25.84%
HRMY annual return on equity is 25.84%

EBIT & EBITDA

Annual EBIT

$209.30 M
HRMY annual earnings before interest & taxes is $209.30 million

Annual EBITDA

$233.41 M
HRMY annual EBITDA is $233.41 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

13.27
HRMY price to earnings ratio is 13.27

PE Ratio Sector Rank

19.5%
HRMY price to earnings ratio is higher than 19.5% of companies in Healthcare sector

PB Ratio

PB Ratio

2.90
HRMY price to book ratio is 2.90

PB Ratio Sector Rank

69.66%
HRMY price to book ratio is higher than 69.66% of companies in Healthcare sector

PS Ratio

PS Ratio

2.67
HRMY price to sales ratio is 2.67

PS Ratio Sector Rank

47.27%
HRMY price to sales ratio is higher than 47.27% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.64 B
HRMY enterprise value is $1.64 billion

Enterprise Value Sector Rank

79.27%
HRMY enterprise value is higher than 79.27% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

7.01
HRMY EV/EBITDA is 7.01

EV/EBITDA Sector Rank

79.58%
HRMY EV/EBITDA is higher than 79.58% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.31
HRMY annual current ratio is 3.31

Annual Quick Ratio

3.27
HRMY annual quick ratio is 3.27

Leverage

Annual Debt To Equity

0.27
HRMY annual debt to equity ratio is 0.27

Annual Interest Coverage Ratio

11.96
HRMY annual interest coverage ratio is 11.96

Risk & Stability

Piotroski F-Score

7
HRMY piotroski f-score is 7

Altman Z-Score

5.26
HRMY altman z-score is 5.26

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$999.20 M
HRMY annual total assets is $999.20 million

Annual Non Current Assets

$419.95 M
HRMY annual long term assets is $419.95 million

Annual Current Assets

$579.25 M
HRMY annual total current assets is $579.25 million

Annual Cash & Cash Equivalents

$453.00 M
HRMY annual cash & cash equivalents is $453.00 million

Equity

Annual Book Value

$659.15 M
HRMY annual book value is $659.15 million

Annual Working Capital

$404.17 M
HRMY annual working capital is $404.17 million

Liabilities

Annual Total Liabilities

$340.05 M
HRMY annual total liabilities is $340.05 million

Annual Total Long Term Liabilities

$164.96 M
HRMY annual total long term liabilities is $164.96 million

Annual Current Liabilities

$175.08 M
HRMY annual total current liabilities is $175.08 million

Annual Accounts Payable

$13.74 M
HRMY annual accounts payable is $13.74 million

Debt

Annual Total Debt

$179.27 M
HRMY annual total debt is $179.27 million

Annual Total Debt 1-Year Change

-7.39%
HRMY annual total debt is down -7.39% year-on-year

Annual Long Term Debt

$163.02 M
HRMY annual long term debt is $163.02 million

Annual Short Term Debt

$16.25 M
HRMY annual short term debt is $16.25 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$523.91 M
HRMY annual total expenses is $523.91 million

Annual Operating Expenses

$367.09 M
HRMY annual total operating expenses is $367.09 million

Annual Cost Of Goods Sold

$156.81 M
HRMY annual cost of goods sold is $156.81 million

Annual SGA

$221.27 M
HRMY annual SGA is $221.27 million

Annual D&A

$24.11 M
HRMY annual depreciation & amortization is $24.11 million

Annual Interest Expense

$17.50 M
HRMY annual interest expense is $17.50 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$219.82 M
HRMY annual cash flow from operations is $219.82 million

Annual CFO 1-Year Change

+0.2%
HRMY annual cash flow from operations is up +0.2% year-on-year

Annual CFI

-$67.48 M
HRMY annual cash flow from investing activities is -$67.48 million

Annual CFI 1-Year Change

-45.32%
HRMY annual cash flow from investing activities is down -45.32% year-on-year

Annual CFF

-$11.00 M
HRMY annual cash flow from financing activities is -$11.00 million

Annual CFF 1-Year Change

+89.58%
HRMY annual cash flow from financing activities is up +89.58% year-on-year

Free CashFlow

Annual FCF

$218.67 M
HRMY annual free cash flow is $218.67 million

Annual FCF 1-Year Change

-0.19%
HRMY annual free cash flow is down -0.19% year-on-year

CAPEX

Annual CAPEX

$1.15 M
HRMY annual capital expenditures is $1.15 million

Annual CAPEX 1-Year Change

+269.55%
HRMY annual capital expenditures is up +269.55% year-on-year

Institutional Ownership

Similar stocks

RXRX logo
Recursion Pharmaceuticals (RXRX)
MESO logo
Mesoblast Limited (MESO)
ATRC logo
AtriCure (ATRC)
AGIO logo
Agios Pharmaceuticals (AGIO)
CERT logo
Certara (CERT)
AZTA logo
Azenta (AZTA)
Disc Medicine (IRON)
PGNY logo
Progyny (PGNY)
KYMR logo
Kymera Therapeutics (KYMR)

FAQ

  • What is the ticker symbol for Harmony Biosciences Holdings?
  • Does Harmony Biosciences Holdings pay dividends?
  • What sector is Harmony Biosciences Holdings in?
  • What industry is Harmony Biosciences Holdings in?
  • What country is Harmony Biosciences Holdings based in?
  • When did Harmony Biosciences Holdings go public?
  • Is Harmony Biosciences Holdings in the S&P 500?
  • Is Harmony Biosciences Holdings in the NASDAQ 100?
  • Is Harmony Biosciences Holdings in the Dow Jones?
  • When was Harmony Biosciences Holdings's last earnings report?
  • When does Harmony Biosciences Holdings report earnings?
  • Should I buy Harmony Biosciences Holdings stock now?

What is the ticker symbol for Harmony Biosciences Holdings?

The ticker symbol for Harmony Biosciences Holdings is NASDAQ:HRMY

Does Harmony Biosciences Holdings pay dividends?

No, Harmony Biosciences Holdings does not pay dividends

What sector is Harmony Biosciences Holdings in?

Harmony Biosciences Holdings is in the Healthcare sector

What industry is Harmony Biosciences Holdings in?

Harmony Biosciences Holdings is in the Biotechnology industry

What country is Harmony Biosciences Holdings based in?

Harmony Biosciences Holdings is headquartered in United States

When did Harmony Biosciences Holdings go public?

Harmony Biosciences Holdings's initial public offering (IPO) was on August 19, 2020

Is Harmony Biosciences Holdings in the S&P 500?

No, Harmony Biosciences Holdings is not included in the S&P 500 index

Is Harmony Biosciences Holdings in the NASDAQ 100?

No, Harmony Biosciences Holdings is not included in the NASDAQ 100 index

Is Harmony Biosciences Holdings in the Dow Jones?

No, Harmony Biosciences Holdings is not included in the Dow Jones index

When was Harmony Biosciences Holdings's last earnings report?

Harmony Biosciences Holdings's most recent earnings report was on Feb 25, 2025

When does Harmony Biosciences Holdings report earnings?

The next expected earnings date for Harmony Biosciences Holdings is Apr 30, 2025

Should I buy Harmony Biosciences Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions